SOSV V L.P. takes 17.6% stake in Bactery Ltd
Published
SOSV V L.P. entered Bactery, a bacteria-powered battery developer, with SEED PREFERRED shares.
Tilia Impact Ventures Fund II SCSP joined with a 9.8% holding in SEED PREFERRED shares.
Adapt [US] Fund I, LP entered with a 1.4% stake in the same class.
Together, the fund entries suggest fresh funding, while continuing ordinary holdings rose because of share scaling. Filed on 10 August 2026 for the period from 2 August 2025 to 2 August 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | SOSV V L.P. | 265,968 | — | SEED PREFERRED 265,968 |
| New shareholder | TILIA IMPACT VENTURES FUND II SCSP | 148,175 | — | SEED PREFERRED 148,175 |
| New shareholder | ADAPT [US] FUND I, LP | 21,168 | — | SEED PREFERRED 21,168 |
| Increased | THE UNIVERSITY OF BATH | 100,000 | +9900% | ORDINARY 100,000 |
Current shareholders (4)
| Shareholder | Total shares | Share classes |
|---|---|---|
| SOSV V L.P. | 265,968 | SEED PREFERRED 265,968 |
| TILIA IMPACT VENTURES FUND II SCSP | 148,175 | SEED PREFERRED 148,175 |
| THE UNIVERSITY OF BATH | 100,000 | ORDINARY 100,000 |
| ADAPT [US] FUND I, LP | 21,168 | SEED PREFERRED 21,168 |
Contact the editorial team at editorial@fundingspotter.com